Daily as of 3 Nov 16:00 ET
- Price
- between the two $28.38 vs 50 $29.32 / 200 $25.03
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 11 Aug 2026 · projected 30 bars out
ZBIO | Zenas BioPharmaNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$28.38
+$0.76 (+2.75%)
Zenas BioPharma (ZBIO) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2025.
The 50 SMA has sat above the 200 on the daily since Aug 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits between the 50 and the 200 on the daily and the 4-hour.
Timeframe summary
Weekly
No weekly data
4-hour as of 3 Nov 16:00 ET
- Price
- between the two $28.38 vs 50 $27.35 / 200 $28.81
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 22 Oct 2026 bar 1 · projected 24 bars out · tested 5 bars
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 22 Oct 2026 | 💀Death | 4-hour | 24 bars out | 5 bar cross test |
| 11 Aug 2026 | 🟨Golden steep | daily | 30 bars out | Not tested |
| 27 Mar 2026 | 💀Death flat | daily | 29 bars out | 3 bar cross test |
| 19 Mar 2026 | 🟨Golden flat | daily | 1 bar out | 5 bar cross test |
| 17 Mar 2026 | 💀Death steep | daily | 12 bars out | 2 bar cross test |
About ZBIO
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$15.7M
4-hour coverageYes, since Oct 2025
History on recordSince 2025
SectorHealthcare
Cap bandmid